Tapete G, Bertani L, Pieraccini A, Lynch EN, et al. Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry. Inflamm Bowel Dis 2022;28:62-69.
PMID: 33570142